ClinicalTrials.Veeva

Menu

Blood Flow Restriction in Post-surgery Rehabilitation of Latarjet Procedure (BFR)

E

Ensemble Hospitalier de la Côte

Status

Not yet enrolling

Conditions

Shoulder Dislocation

Treatments

Device: Blood flow restriction (50% AOP compression) in the rehabilitation phase after Latarjet surgery for chronic shoulder instability
Device: Blood flow restriction (10% AOP compression) in the rehabilitation phase after Latarjet surgery for chronic shoulder instability

Study type

Interventional

Funder types

Other

Identifiers

NCT06430567
EHC Morges BFR

Details and patient eligibility

About

The goal of this clinical trial is to evaluate the effects of Blood Flow Restriction (BFR) training on post-surgery rehabilitation following the Latarjet procedure in athletes aged 18-35.

The main questions it aims to answer are:

Does BFR training improve scapular belt muscle strength post-surgery? Does BFR training enhance shoulder function during rehabilitation?

Researchers will compare three groups:

BFR Group with 50% AOP [arterial occlusion pressure] compression BFR Placebo Group with 10% AOP compression Control Group

Participants will:

Perform the same four strengthening exercises twice a week Complete 16 semi-autonomous strength training sessions over 8 weeks Undergo isokinetic and isometric strength tests, shoulder mobility assessments, and complete self-assessment questionnaires.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: 18-35 years
  • Indication for shoulder stabilization surgery using the Latarjet procedure (documented anterior dislocations with proof of emergency reduction, with or without hypermobility and confirmation of traumatic capsulo-ligamentous injury by MRI).
  • Regular exercise (min. 1x / week)
  • Signed the informed consent form for the study.

Exclusion criteria

  • Pregnant or breast-feeding women
  • Active oncological disease under treatment. (Patient with stable oncological disease eligible)
  • Adverse events during the 6-week post-operative period such as:-Fracture/displacement of the reconstructed bone-Luxation of the operated shoulder-Requirement for emergency hospitalization
  • History of deep vein thrombosis/pulmonary embolism
  • Inability to follow study procedures, due to language problems, psychological disorders, dementia.
  • Need for skin grafting following shoulder stabilization surgery
  • Coronary heart disease
  • Unstable hypertension
  • Peripheral vascular disease
  • Hypercoagulable states (blood coagulation disorders)
  • Left ventricular dysfunction
  • Hemophilia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

50 participants in 3 patient groups, including a placebo group

Control
No Intervention group
Description:
Patient will not use BFR
Placebo 10% of pressure for arterial occlusion
Placebo Comparator group
Description:
Patient will use BFR sub optimally as described in the literature
Treatment:
Device: Blood flow restriction (10% AOP compression) in the rehabilitation phase after Latarjet surgery for chronic shoulder instability
Interventional 50% of pressure for arterial occlusion
Experimental group
Description:
Patient will use the minimal pressure of 50% of arterial occlusion known to be effective in the literature
Treatment:
Device: Blood flow restriction (50% AOP compression) in the rehabilitation phase after Latarjet surgery for chronic shoulder instability

Trial contacts and locations

0

Loading...

Central trial contact

Arnaud Meylan, MD; Bauer Stefan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems